Literature DB >> 7957812

Conversion of 9-nitro-camptothecin to 9-amino-camptothecin by human blood cells in vitro.

P Pantazis, N Harris, J Mendoza, B Giovanella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7957812     DOI： 10.1111/j.1600-0609.1994.tb00199.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  4 in total

1.  Control-relevant modeling of the antitumor effects of 9-nitrocamptothecin in SCID mice bearing HT29 human colon xenografts.

Authors:  John M Harrold; Julie L Eiseman; Erin Joseph; Sandra Strychor; William C Zamboni; Robert S Parker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

Review 2.  Oral topoisomerase 1 inhibitors in adult patients: present and future.

Authors:  H A Gelderblom; M J DE Jonge; A Sparreboom; J Verweij
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  Topoisomerase I inhibitors and drug resistance.

Authors:  R E Parchment; A Pessina
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 4.  Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.

Authors:  C J Gerrits; M J de Jonge; J H Schellens; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.